Press Digest: Financial Times - March 20

Fusion Pharmaceuticals

20/03/2024 24:39

March 20 (Reuters) - The following are the top stories
in the Financial Times. Reuters has not verified these stories
and does not vouch for their accuracy.
    
    Headlines
    
    - Ted Baker preparing to appoint administrators
    
    - Telegraph takeover by RedBird IMI faces regulatory probe
    
    - AstraZeneca strikes $2.4 bln deal for radiotherapy biotech
Fusion
    
    - Unilever to split off ice cream business and cut 7,500
jobs
    
 
    
    Overview
    
    - British fashion retailer Ted Baker is on the brink of
collapse unless it finds a new business partner, casting doubt
over the future of hundreds of high street jobs at the UK
fashion brand.
    
    - Telegraph Media Group's takeover by Abu Dhabi-backed
RedBird IMI could face an in-depth regulatory review, giving the
UK government more time to change the law to formally block the
deal in the next few months.
    
    - AstraZeneca  AZN.L  said it has agreed to buy
clinical-stage biopharmaceutical company Fusion Pharmaceuticals
Inc  FUSN.O  for $2.4 billion.
    
    -  Unilever  ULVR.L  said it would spin off its ice cream
unit, home to popular brands such as Magnum and Ben & Jerry's,
and cut 7,500 jobs in a new cost-savings programme.
  

   ($1 = 0.7862 pounds)

 (Compiled by Bengaluru newsroom)
 ((globalnewsmonitoring@thomsonreuters.com))